n=15 543 | Total individuals | Median time spent in work disability (years) (CI 95%) | 3-year cumulative probability of ending work disability | Work disability (censored) | ||
n (%) | Death | Retirement | Ability to work | |||
Year of entry | ||||||
2007 | 3454 (22.2) | 1.89 (1.780 to 2.048) | 29.04 (27.52–30.55) | 1.51 (1.10–1.91) | 28.69 (27.18–30.20) | 40.76 (36.74–44.78) |
2008 | 3760 (24.2) | 1.83 (1.717 to 1.960) | 28.64 (27.20–30.09) | 1.65 (1.24–2.06) | 30.13 (28.67–31.60) | 39.57 (35.62–43.52) |
2009 | 3630 (23.4) | 1.76 (1.621 to 1.889) | 28.76 (27.29–30.23) | 0.74 (0.46–1.02) | 30.61 (29.11–32.11) | 39.89 (35.90–43.88) |
2010 | 3388 (21.8) | 1.54 (1.410 to 1.670) | 27.54 (26.03–29.04) | 0.56 (0.31–0.81) | 32.29 (30.72–33.86) | 39.61 (35.45–43.77) |
2011 | 1311 (8.4) | 0.45 (0.413 to 0.487) | 31.59 (29.01–34.17) | 0.54 (0.14–0.93) | 46.76 (44.04–49.47) | 21.12 (10.23–32.00) |
Age at entry | ||||||
17–39 | 2421 (15.6) | 1.51 (1.415 to 1.69) | 18.46 (16.91–20.00) | – | 45.53 (43.54–47.52) | 36.01 (30.69–41.33) |
40–49 | 5052 (32.5) | 1.76 (1.637 to 1.88) | 22.74 (21.59–23.90) | – | 36.17 (34.84–37.49) | 41.09 (37.78–44.39) |
50–59 | 6946 (44.7) | 1.70 (1.580 to 1.79) | 34.21 (33.10–35.33) | – | 25.51 (24.48–26.53) | 40.28 (37.41–43.15) |
≥60 | 1121 (7.2) | 0.91 (0.797 to 1.06) | 44.19 (41.28–47.10) | 14.95 (12.86–17.04) | 21.51 (19.10–23.92) | 19.34 (7.36–31.33) |
Gender | ||||||
Male | 5874 (38) | 1.18 (1.12 to 1.26) | 43.52 (42.26–44.79) | 1.5 (1.19–1.82) | 23.15 (22.08–24.23) | 31.82 (28.07–35.57) |
Female | 9669 (62) | 1.94 (1.84 to 2.05) | 19.78 (18.98–20.57) | 0.82 (0.64–1.00) | 37.06 (36.09–38.02) | 42.35 (40.02–44.67) |
Occupational class | ||||||
Blue collar | 7715 (50) | 1.79 (1.72 to 1.89) | 31.43 (30.39–32.46) | 0.59 (0.42–0.76) | 26.65 (25.66–27.63) | 41.34 (38.68–44.00) |
White collar | 5703 (37) | 1.30 (1.23 to 1.37) | 24.46 (23.34–25.57) | 0.63 (0.43–0.84) | 40.74 (39.47–42.02) | 34.17 (30.56–37.78) |
Assisting spouse and self-employed | 2125 (13) | 1.79 (1.63 to 1.97) | 30.56 (28.60–32.53) | 4.08 (3.24–4.92) | 26.53 (24.66–28.41) | 38.82 (33.47–44.18) |
Cancer site | ||||||
CIS/Benign | 614 (4) | 4.98 (3.24 to 6.72) | 10.76 (8.31–13.21) | 1.14 (0.30–1.98) | 33.07 (29.35–36.79) | 55.03 (47.87–62.18) |
Head and neck | 877 (5.6) | 1.69 (1.41 to 1.93) | 44.43 (41.14–47.73) | 0.35 (0.00–0.74) | 17.69 (15.17–20.22) | 37.53 (28.97–46.08) |
Digestive tract | 2400 (15.4) | 1.31 (1.18 to 1.41) | 42.15 (40.18–44.13) | 1.76 (1.23–2.28) | 23.98 (22.27–25.69) | 32.11 (26.29–37.94) |
Respiratory tract | 1417 (9.1) | 0.75 (0.69 to 0.83) | 69.91 (67.52–72.30) | 0.86 (0.37–1.34) | 9.47 (7.94–10.99) | 19.77 (9.26–30.28) |
Haematological | 1660 (10.7) | 1.83 (1.66 to 2.08) | 20.56 (18.62–22.51) | 0.91 (0.45–1.36) | 37.39 (35.06–39.72) | 41.14 (35.38–46.90) |
Breast | 5511 (35.0) | 2.10 (1.95 to 2.30) | 10.29 (9.49–11.09) | 0.78 (0.55–1.02) | 44.80 (43.49–46.12) | 44.13 (41.15–47.10) |
Female genital organs | 821 (5.3) | 1.56 (1.37 to 1.82) | 34.50 (31.25–37.76) | 0.12 (0.00–0.36) | 28.76 (25.67–31.86) | 36.61 (27.60–45.62) |
Male genital organs | 486 (3.1) | 1.73 (1.52 to 2.24) | 17.93 (14.52–21.35) | 6.21 (4.06–8.36) | 36.25 (31.97–40.53) | 39.60 (28.60–50.61) |
Urinary tract | 388 (2.5) | 1.67 (1.32 to 2.16) | 38.19 (33.35–43.03) | 1.55 (0.32–2.78) | 21.39 (17.31–25.47) | 38.86 (26.37–51.36) |
CNS | 709 (4.6) | 1.46 (1.18 to 1.89) | 45.92 (42.25–49.60) | 0.42 (0.00–0.90) | 16.23 (13.52–18.95) | 37.42 (27.88–46.96) |
Bone and connective tissue (sarcomas)/skin/thyroid | 660 (4.2) | 1.24 (1.03 to 1.52) | 39.13 (35.40–42.86) | 0.76 (0.10–1.42) | 26.55 (23.18–29.92) | 33.56 (22.81–44.31) |
Total, n (%) | 15 543 | 1.59 (1.52 to 1.66) | 4468 (29%) | 167 (1%) | 4943 (32%) | 5964 (38%) |
CIS, carcinoma in situ; CNS, central nervous system.